Status:
UNKNOWN
Study on Early Stage Bulky Cervical Cancers
Lead Sponsor:
Rajkumar Kottayasamy Seenivasagam
Conditions:
Carcinoma Cervix
Eligibility:
FEMALE
18-60 years
Phase:
PHASE3
Brief Summary
The aim of this study is to establish the role of neoadjuvant chemotherapy and chemo irradiation in carcinoma cervix and to compare its results with the concurrent chemo irradiation in terms of overal...
Detailed Description
Early stage bulky cancers of the cervix, (defined as FIGO Stages IB2, IIA2 and IIB) form a distinctive subset of "curable" cervical cancers with good 5 year survival rates with adequate treatment. Con...
Eligibility Criteria
Inclusion
- Patients with histologically confirmed bulky cervical Squamous cell carcinoma (FIGO stage IB2, II A2, IIB).
- Age 18-60 years
- Karnofsky performance status of ≥70%; ECOG PS ≤ 2
Exclusion
- Nonsquamous Histologies
- Other systemic diseases, comorbidities precluding full participation in the study
- Concomitant treatment with any experimental drug
- Pregnant or nursing women
- Previous or concomitant malignant diseases other than non-melanoma skin cancer
- Previous radiation to the pelvis
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2018
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01917695
Start Date
August 1 2013
End Date
August 1 2018
Last Update
August 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Government Royapettah Hospital
Chennai, Tamil Nadu, India, 600014IndiaNaduI6